medicalxpress - A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research published in the journal Nature Communications. Scientists from the Breast Cancer Now Toby Robins Re…
#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch
Saturday, March 14, 2026, 11:21 pm / permalink 20776 / 4 stories in 43 hrs
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (14 hrs)
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (15 hrs)
Vitamin D trial shows reduced long‑COVID risk but no severity benefit (17 hrs)
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (15 hrs)
Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (18 hrs)
FDA approves leucovorin for rare folate disorder despite autism hype (30 hrs)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.